NxStage Medical, Inc. is a medical technology company, which develops, manufactures, and markets products for the treatment of ESRD and acute kidney failure. It operates through the following business segments: System One, In-Center, and Services. The System One segment engages in the sale and rental of the System One and PureFlow SL equipment and the sale of disposable products in the home and critical care markets. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers and needles for apheresis. The Services segment includes revenues from dialysis services provided to patients at its recently opened NxStage Kidney Care dialysis centers. The company was founded by Jeffrey H. Burbank in December 1998 and is headquartered in Lawrence, MA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
Frequently Asked Questions
What is Market Cap of NxStage Medical, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. NxStage Medical, Inc. market cap is N/A.
What is the 52-week high for NxStage Medical, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. NxStage Medical, Inc. 52 week high is N/A as of September 17, 2025.
What is the 52-week low for NxStage Medical, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. NxStage Medical, Inc. 52 week low is N/A as of September 17, 2025.
What is NxStage Medical, Inc. stock price today?
NxStage Medical, Inc. stock price today is $30.00.
What was NxStage Medical, Inc. stock price yesterday?
NxStage Medical, Inc. stock price yesterday was $29.99.
What is the PE ratio of NxStage Medical, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. NxStage Medical, Inc.’s P/E ratio is None.
What is the Price-to-Book ratio of NxStage Medical, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. NxStage Medical, Inc. P/B ratio is None.
What is NxStage Medical, Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. NxStage Medical, Inc.'s EBITDA is 57.63.
What is the 50-day moving average of NxStage Medical, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. NxStage Medical, Inc. 50-day moving average is N/A.
How many employess does NxStage Medical, Inc. has?
